BUZZ-Biocytogen hits record high on green light of Shanghai listing plan
Reuters
Sep 25
BUZZ-Biocytogen hits record high on green light of Shanghai listing plan
** Shares of Biocytogen Pharmaceuticals (Beijing) 2315.HK jump 9.6% to HK$30.58, their highest level since debut in September 2022, and on course for a second session of gains
** Stock set for the biggest one-day pct gain since September 18
** The China-based drug developer said on Wednesday the listing committee for the Sci-Tech Board of the Shanghai Stock Exchange has approved the company's plan to issue and listing of its A shares on the Sci-Tech Board in Shanghai
** YTD, stock up 258.6%, Hang Seng Biotech Index .HSBIO up 100.7%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.